Santhera Pharmaceuticals Holding AG
SANN | SW
Overview
Corporate Details
- ISIN(s):
- CH1276028821
- LEI:
- 54930035HAOFTTQH0U85
- Country:
- Switzerland
- Address:
- HOHENRAINSTRASSE 24, 4133 PRATTELN
- Website:
- https://www.santhera.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
We are focusing on the development of treatments for neuromuscular and pulmonary diseases that currently lack treatment options, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). We have dedicated more than a decade to researching potential treatments in our ongoing mission to make effective medicines available for these often overlooked, life-altering diseases. We are passionate about improving patients’ quality of life and our vision is to be a leader in providing treatments for rare diseases in these areas with high unmet medical needs.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for Santhera Pharmaceuticals Holding AG.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| No filings match the current criteria. | ||||
Automate Your Workflow. Get a real-time feed of all Santhera Pharmaceuticals Holding AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Santhera Pharmaceuticals Holding AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2022-01-11 | N/A | Non-Executive member | Buy | None | 42,600.00 CHF |
| 2022-01-10 | N/A | Executive member | Buy | None | 14,420.00 CHF |
| 2022-01-05 | N/A | Executive member | Buy | None | 37,000.00 CHF |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
MorphoSys AG | Germany | MOR | |
|
MPH Health Care | Germany | 93M1 | |
|
MUROMACHI CHEMICALS INC. | Japan | 4885 | |
|
NANO MRNA Co.,Ltd. | Japan | 4571 | |
|
NATAC | Spain | NAT | |
|
Navamedic | Norway | NAVA | |
|
Newbury Pharmaceuticals AB | Sweden | NEWBRY | |
|
New Nordic Healthbrands AB | Sweden | NNH | |
|
Nicoccino Holding AB | Sweden | NICO | |
|
Nicox S.A. | France | COX |